Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal Of The National Comprehensive Cancer Network : JNCCN
Published:
Abstract
Thymomas and thymic carcinomas are rare mediastinal tumors that originate in the thymus. Patients with thymoma may experience symptoms associated with autoimmune paraneoplastic diseases (such as myasthenia gravis), which typically do not occur in patients with thymic carcinoma. The NCCN Guidelines for Thymomas and Thymic Carcinomas provide guidance for the diagnosis, treatment, and surveillance of patients with thymoma and thymic carcinoma. Involvement of a multidisciplinary team with experience treating thymomas and thymic carcinomas is highly recommended.
Authors
Gregory Riely, Douglas Wood, Billy Loo, Dara Aisner, Wallace Akerley, Jessica Bauman, Ankit Bharat, Joe Chang, Lucian Chirieac, Malcolm Decamp, Aakash Desai, Thomas Dilling, Jonathan Dowell, Gregory Durm, Scott Gettinger, Travis Grotz, Matthew Gubens, Aditya Juloori, Rudy Lackner, Michael Lanuti, Jules Lin, Christine Lovly, Fabien Maldonado, Daniel Morgensztern, Trey Mullikin, Thomas Ng, Dawn Owen, Dwight Owen, Sandip Patel, Tejas Patil, Patricio Polanco, Jonathan Riess, Theresa Shapiro, Aditi Singh, James Stevenson, Alda Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen Yang, Edwin Yau, Kristina Gregory, Lisa Hang
Relevant Conditions